Komori
Susmed (4263) · RiskFirst stated

Risk of disruption to ongoing relationships with partner companies

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Dependence on Alliance Partners' Technology, R&D and Management PoliciesA theme 27 companies write about · 29 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 3 of 9 companies on the "Worse" side.

2 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 27 companies compared. The sentences above are computed from all 27.
Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「However, a review of development policies resulting from major events at partner companies, such as changes in business strategy, deterioration in business conditions, or organizational restructuring, could make it difficult to maintain the contractual relationships.」

    The company separately identified the risk of losing development cost contributions, milestone revenue, and royalties due to changes in the business strategies, deterioration in business conditions, or organizational restructuring of partner companies, including pharmaceutical companies.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Susmed yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of disruption to ongoing relationships with partner companies | SUSMED,Inc. (4263) | Komori